Clinical Trial Update: Effects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung Cancer [NA]

View source ↗

Summary

A clinical trial evaluating a visual interactive LINE chatbot to help patients with non-small cell lung cancer self-manage EGFR-TKI related side effects. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Non-Small Cell Lung Cancer | NA | Status: NOT_YET_RECRUITING